Literature DB >> 20335546

A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases.

Inès Birlouez-Aragon1, Giselle Saavedra, Frédéric J Tessier, Anne Galinier, Lamia Ait-Ameur, Florence Lacoste, Claude-Narcisse Niamba, Nadja Alt, Veronika Somoza, Jean-Michel Lecerf.   

Abstract

BACKGROUND: The modern Western lifestyle is characterized by the consumption of high-heat-treated foods because of their characteristic taste and flavor. However, it has been shown that treating food at high temperatures can generate potentially harmful compounds that promote inflammation and cardiovascular disease in subjects with diabetes.
OBJECTIVE: The aim of this study was to determine whether high-heat-treated foods also pose a risk for healthy subjects.
DESIGN: A randomized, crossover, diet-controlled intervention trial with 62 volunteers was designed to compare the potential metabolic effects of 2 diets, one that was based on mild steam cooking and another that was based on high-temperature cooking. These 2 diets differed mainly in their contents of Maillard reaction products (MRPs). MRPs were assessed in the diet and in subjects' feces, blood, and urine samples, with N(epsilon)-carboxymethyllysine as an indicator of MRPs. Biological indicators of glucose and lipid metabolism as well as oxidative stress were analyzed in subjects after 1 mo on each diet.
RESULTS: In comparison with the steamed diet, 1 mo of consuming the high-heat-treated diet induced significantly lower insulin sensitivity and plasma concentrations of long-chain n-3 (omega-3) fatty acids and vitamins C and E [-17% (P < 0.002), -13% (P < 0.0001), and -8% (P < 0.01), respectively]. However, concentrations of plasma cholesterol and triglycerides increased [+5% (P < 0.01) and +9% (P < 0.01), respectively].
CONCLUSIONS: A diet that is based on high-heat-treated foods increases markers associated with an enhanced risk of type 2 diabetes and cardiovascular diseases in healthy people. Replacing high-heat-treatment techniques by mild cooking techniques may help to positively modulate biomarkers associated with an increased risk of diabetes mellitus and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335546     DOI: 10.3945/ajcn.2009.28737

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  61 in total

Review 1.  Does accumulation of advanced glycation end products contribute to the aging phenotype?

Authors:  Richard D Semba; Emily J Nicklett; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-05-17       Impact factor: 6.053

2.  The gut as a sensory organ.

Authors:  John B Furness; Leni R Rivera; Hyun-Jung Cho; David M Bravo; Brid Callaghan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-24       Impact factor: 46.802

Review 3.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

Review 4.  Dietary advanced glycation end products and their role in health and disease.

Authors:  Jaime Uribarri; María Dolores del Castillo; María Pía de la Maza; Rosana Filip; Alejandro Gugliucci; Claudia Luevano-Contreras; Maciste H Macías-Cervantes; Deborah H Markowicz Bastos; Alejandra Medrano; Teresita Menini; Manuel Portero-Otin; Armando Rojas; Geni Rodrigues Sampaio; Kazimierz Wrobel; Katarzyna Wrobel; Ma Eugenia Garay-Sevilla
Journal:  Adv Nutr       Date:  2015-07-15       Impact factor: 8.701

5.  Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.

Authors:  Nicole J Kellow; Melinda T Coughlan; Christopher M Reid
Journal:  Eur J Nutr       Date:  2017-06-27       Impact factor: 5.614

Review 6.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

7.  Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.

Authors:  Weijing Cai; Jaime Uribarri; Li Zhu; Xue Chen; Shobha Swamy; Zhengshan Zhao; Fabrizio Grosjean; Calogera Simonaro; George A Kuchel; Michal Schnaider-Beeri; Mark Woodward; Gary E Striker; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

8.  Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.

Authors:  Richard D Semba; Sarah K Gebauer; David J Baer; Kai Sun; Randi Turner; Harry A Silber; Sameera Talegawkar; Luigi Ferrucci; Janet A Novotny
Journal:  J Nutr       Date:  2014-04-17       Impact factor: 4.798

9.  Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.

Authors:  Weijing Cai; Maya Ramdas; Li Zhu; Xue Chen; Gary E Striker; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

10.  Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.

Authors:  Helen Vlassara; Weijing Cai; Elizabeth Tripp; Renata Pyzik; Kalle Yee; Laurie Goldberg; Laurie Tansman; Xue Chen; Venkatesh Mani; Zahi A Fayad; Girish N Nadkarni; Gary E Striker; John C He; Jaime Uribarri
Journal:  Diabetologia       Date:  2016-07-29       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.